Protalix BioTherapeutics (PLX) Receivables (2009 - 2026)
Protalix BioTherapeutics' Receivables came in at $16.5 million for Q2 2026, up 74.8% from $9.44 million a year earlier and up 461.5% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics' Receivables was $8.84 million, up 203.9% from FY2024.
- Receivables carries a five-year compound annual growth rate of 34.6% (FY2020 to FY2025).
- Going back by year, Receivables was $2.91 million in FY2024 (-44.8%), $5.27 million in FY2023 (+15.0%), $4.59 million in FY2022 (+33.2%) and $3.44 million in FY2021 (+72.1%).
- The Q2 2026 figure represents the highest quarterly Receivables in data going back to Q4 2010.
- Year-over-year, Receivables increased in four of the last eight quarters, with growth averaging 87.0%.
- The fastest year-over-year change in Receivables over five years came in Q3 2025 (growth of 557.2%), and the weakest in Q1 2023 (a decline of 77.9%).
- Business Quant data shows PLX's Receivables at $2.94 million (Q1 2026), $8.84 million (Q4 2025) and $14.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 13.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.91 Mn |
| Jun 30, 2026 | 16.50 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 8.84 Mn |
| Sep 30, 2025 | 14.43 Mn |
| Jun 30, 2025 | 9.44 Mn |
| Mar 31, 2025 | 4.68 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 10.13 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 5.27 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 4.05 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 4.59 Mn |
| Sep 30, 2022 | 8.65 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 5.91 Mn |
| Dec 31, 2021 | 3.44 Mn |
API Access
Protalix BioTherapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();